Skip to main content

Advertisement

Log in

Vitamin D Receptor Gene Variants and Esophageal Adenocarcinoma Risk: A Population-Based Case–Control Study

  • Brief Communication
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

Polymorphisms in the vitamin D receptor (VDR) gene may be of etiological importance in determining cancer risk. The aim of this study was to assess the association between common VDR gene polymorphisms and esophageal adenocarcinoma (EAC) risk in an all-Ireland population-based case–control study.

Methods

EAC cases and frequency-matched controls by age and gender recruited between March 2002 and December 2004 throughout Ireland were included. Participants were interviewed, and a blood sample collected for DNA extraction. Twenty-seven single nucleotide polymorphisms in the VDR gene were genotyped using Sequenom or TaqMan assays while the poly(A) microsatellite was genotyped by fluorescent fragment analysis. Unconditional logistic regression was applied to assess the association between VDR polymorphisms and EAC risk.

Results

A total of 224 cases of EAC and 256 controls were involved in analyses. After adjustment for potential confounders, TT homozygotes at rs2238139 and rs2107301 had significantly reduced risks of EAC compared with CC homozygotes. In contrast, SS alleles of the poly(A) microsatellite had significantly elevated risks of EAC compared with SL/LL alleles. However, following permutation analyses to adjust for multiple comparisons, no significant associations were observed between any VDR gene polymorphism and EAC risk.

Conclusions

VDR gene polymorphisms were not significantly associated with EAC development in this Irish population. Confirmation is required from larger studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Renal Physiol. 2005;289:F8–28.

    Article  CAS  Google Scholar 

  2. Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signalling is modulated on multiple levels in health and disease. Mol Cell Endocrinol. 2006;248:149–59.

    Article  PubMed  CAS  Google Scholar 

  3. Anderson PH, May BK, Morris HA. Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev. 2003;24:13–26.

    PubMed  CAS  Google Scholar 

  4. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41:1164–9.

    Article  PubMed  CAS  Google Scholar 

  5. Holick CN, Stanford JL, Kwon EM, et al. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1 and CYP24A1, in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1990–9.

    Article  PubMed  CAS  Google Scholar 

  6. Pera M, Manterola C, Vidal O, et al. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151–9.

    Article  PubMed  Google Scholar 

  7. De Gottardi A, Dumonceau JM, Bruttin F, et al. Expression of the bile acid receptor FXR in Barrett’s esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer. 2006;5:48–58.

    Article  PubMed  Google Scholar 

  8. Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66:4975–82.

    Article  PubMed  CAS  Google Scholar 

  9. Mulholland HG, Cantwell MM, Anderson LA, et al. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Cancer Causes Control. 2009;20:279–88.

    Article  PubMed  Google Scholar 

  10. Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585–94.

    PubMed  Google Scholar 

  11. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999;80 Suppl 1:95–103.

    PubMed  Google Scholar 

  12. Nejentsev S, Godfrey L, Snook H, et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet. 2004;13:1633–9.

    Article  PubMed  CAS  Google Scholar 

  13. Slatter ML, Yakumo K, Hoffman M. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control. 2001;12:359–64.

    Article  PubMed  CAS  Google Scholar 

  14. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy–Weinberg equilibrium. Am J Hum Genet. 2005;76:887–93.

    Article  PubMed  CAS  Google Scholar 

  15. Whitfield GK, Remus LS, Jurutka PW, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177:145–59.

    Article  PubMed  CAS  Google Scholar 

  16. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.

    Article  PubMed  CAS  Google Scholar 

  17. Li D, Diao Y, Li H, et al. Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous dysplasia and carcinoma. Arch Med Res. 2008;39:594–600.

    Article  PubMed  CAS  Google Scholar 

  18. Mulholland HG, Murray LJ, Anderson LA, et al. Vitamin D, calcium and dairy intake and risk of oesophageal adenocarcinoma and its pre-cursor conditions. Br J Nutr. 2011;011(9):1–10.

    Google Scholar 

  19. Köstner K, Denzer N, Müller CS, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511–36.

    PubMed  Google Scholar 

Download references

Acknowledgments

The FINBAR study group members include LJ Murray (Queen’s University Belfast), LA Anderson (Queen’s University Belfast), BT Johnston (Belfast Health & Social Care Trust), RGP Watson (Belfast Health & Social Care Trust), J McGuigan (Belfast Health & Social Care Trust), HR Ferguson (Belfast Health & Social Care Trust), SJ Murphy (St Vincent’s Hospital Dublin), JV Reynolds (St James’ Hospital, Dublin) and H Comber (National Cancer Registry of Ireland). We appreciate the contributions made by the study participants, their families and all who assisted with the study, particularly the Northern Ireland Cancer Registry and National Cancer Registry Cork. This research was supported by funding from the Ulster Cancer Foundation, the Northern Ireland R&D office and the Health Research Board.

Conflicts of Interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to L. J. Murray.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, C.K., Mulholland, H.G., Cantwell, M.M. et al. Vitamin D Receptor Gene Variants and Esophageal Adenocarcinoma Risk: A Population-Based Case–Control Study. J Gastrointest Canc 43, 512–517 (2012). https://doi.org/10.1007/s12029-011-9322-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-011-9322-9

Keywords

Navigation